Skip to main content

Table 3 Results of the univariate analyses per clinical outcome

From: Advancing current approaches to disease management evaluation: capitalizing on heterogeneity to understand what works and for whom

Clinical outcome

Care groups (N)

Patients (N)

Mean difference [95% CI]

Heterogeneity (I2)

HbA1c (mmol/mol)

18

75,127

0.17 [−0.60, 0.93]

98%*

LDL (mmol/l)

18

58,697

−0.09 [−0.13, -0.05]*

93%*

SBP (mmHg)

18

73,437

−0.95 [−1.25, -0.64]*

57%*

BMI (kg/m2)

18

63,341

−0.04 [−0.10, 0.02]

0%

  1. NOTE: * Statistically significant (p < 0.05).